Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about “Incidentalomas”? Results of a Long-Term Follow-Up
We retrospectively collected all ultrasound imaging data of our thalassemia patients over a period of 10 years with the aim of assessing the prevalence and the risk factors of renal stones and cysts. Moreover, we assessed the incidence of renal-cell carcinoma (RCC) among thalassemia patients (133 with thalassemia major (TM) and 157 with thalassemia intermedia (TI)) and its association with demographic and clinical findings. Renal stones were detected in 15.2% of patients. In the multivariable Cox regression analysis, the independent predictors were blood consumption, splenectomy, and proteinuria. Renal cysts were detected in 18.4% of patients. In the multivariable analysis, age emerged as the only independent predictor. After the first detection, 35% of the patients showed changes in the number, size, or grading of renal cysts. During the study period, the crude incidence rate of RCC was 75.9 cases per 100,000 person-years. The most frequent histological subtype (80%) included clear-cell RCC. In total, 80% of patients with RCC had TM and all were positive for hepatitis C virus antibodies. Thalassemia patients are significantly affected by asymptomatic renal diseases such as stones, cysts, and cancer, suggesting the need for regular screening by imaging.
Authors
- Antonella Meloni (ORCID: https://orcid.org/0000-0002-2284-8585)
- Anna Spasiano
- Filippo Cademartiri (ORCID: https://orcid.org/0000-0002-0579-3279)
- Paolo Ricchi (ORCID: https://orcid.org/0000-0001-7361-3308)
- Carmina Fatigati
- Silvia Costantini
- Flora Ascione
Institutions
- Azienda di Rilievo Nazionale ed Alta Specializzazione (IT)
- Fondazione Toscana Gabriele Monasterio (IT)
- Regione Toscana
Publication Details
- Journal
- Diagnostics
- Published
- 2024-09-15
- DOI
- https://doi.org/10.3390/diagnostics14182047
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Third Health Programme